The prevalence of personality disorders in the community : a global systematic review and meta-analysis by Winsper, Catherine et al.
  
 
 
 
warwick.ac.uk/lib-publications 
 
 
 
 
 
Manuscript version: Author’s Accepted Manuscript 
The version presented in WRAP is the author’s accepted manuscript and may differ from the 
published version or Version of Record. 
 
Persistent WRAP URL: 
http://wrap.warwick.ac.uk/118371 
  
 
How to cite: 
Please refer to published version for the most recent bibliographic citation information.  
If a published version is known of, the repository item page linked to above, will contain 
details on accessing it. 
 
Copyright and reuse: 
The Warwick Research Archive Portal (WRAP) makes this work by researchers of the 
University of Warwick available open access under the following conditions.  
 
Copyright © and all moral rights to the version of the paper presented here belong to the 
individual author(s) and/or other copyright owners. To the extent reasonable and 
practicable the material made available in WRAP has been checked for eligibility before 
being made available. 
 
Copies of full items can be used for personal research or study, educational, or not-for-profit 
purposes without prior permission or charge. Provided that the authors, title and full 
bibliographic details are credited, a hyperlink and/or URL is given for the original metadata 
page and the content is not changed in any way. 
 
Publisher’s statement: 
Please refer to the repository item page, publisher’s statement section, for further 
information. 
 
For more information, please contact the WRAP Team at: wrap@warwick.ac.uk. 
 
 
 
 1 
 
The prevalence of personality disorders in the community: A global 
systematic review and meta-analysis 
 
 
Catherine Winsper, Ph.D., Centre for Mental Health and Wellbeing Research, Warwick 
Medical School, University of Warwick and R & I Department, Caludon Centre, Coventry and 
Warwickshire Partnership Trust, Clifford Bridge, Coventry, CV2 2TE; 
Ayten Bilgin, Ph.D., Psychology Department, Istanbul Medeniyet University;  
Andrew Thompson, Principal research fellow, Orygen, the National Centre of Youth Mental 
Health, University of Melbourne and Warwick Medical School, University of Warwick;    
Steven Marwaha, Ph.D., Institute for Mental Health, Birmingham University and the Barberry, 
National Centre for Mental Health;  
Andrew M. Chanen, MBBS; PhD; FRANZCP, Orygen, the National Centre of Excellence in 
Youth Mental Health and Centre for Youth Mental Health, The University of Melbourne;  
Swaran. P. Singh, DM. Centre for Mental Health and Wellbeing Research, University of 
Warwick; 
Ariel Wang, Division of Mental Health and Wellbeing, Warwick Medical School, University of 
Warwick; 
Vivek Furtado, Division of Mental Health and Wellbeing, Warwick Medical School, University 
of Warwick. 
 
Correspondence concerning this article should be addressed to Catherine Winsper, Mental 
Health and Wellbeing, Warwick Medical School, University of Warwick, Coventry, CV4 7AL, 
UK. Tel +44 (0) 2476 574 886; Fax: +44 (0) 2476 528 375; Contact: 
catherine.winsper@warwick.ac.uk 
Word count: Main text: 3, 540; Abstract: 240  
 
Acknowledgments  
S.P.S receives funding from CLAHRC (Collaborations for Leadership in Applied Health 
Research and Care). The views expressed are those of the authors and not necessarily those of 
 
 
 2 
 
the CLAHRC-WM. C.W has full access to the data in the study and takes responsibility for the 
integrity of the data and accuracy of the analysis.  
Study concept and design: Winsper, Furtado 
Acquisition, analysis and interpretation of data: Winsper, Bilgin. 
Drafting of manuscript: Winsper 
Critical revision of manuscript: All authors 
Statistical analysis: Winsper 
Intellectual content: All authors 
Conflict of Interest Disclosure: None reported. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 3 
 
Background  
Personality disorders are now internationally recognised as a mental health priority. Nevertheless, 
there are no systematic reviews examining the global prevalence of personality disorders. 
Aims 
To calculate the worldwide prevalence of personality disorders and examine whether rates vary 
between high and low and middle-income countries (LAMICs). 
Method  
We systematically searched PsycINFO, MEDLINE, EMBASE and PubMed from 1980 to May 
2018 to identify articles reporting personality disorder prevalence rates in community 
populations (PROSPERO registration number: CRD42017065094).  
Results  
Forty-six studies (from 21 different countries spanning six continents) satisfied inclusion criteria. 
The worldwide pooled prevalence of any personality disorder was 7.8 % (95% Confidence 
Intervals: 6.1-9.5). Rates were greater in high income (9.6%; 95% CI: 7.9-11.3%) compared with 
LAMI (4.3%; 95% CI =2.6-6.1%) countries. In univariate meta-regressions, significant 
heterogeneity was partly attributable to study design (two-stage versus one-stage assessment), 
county income (high versus LAMI) and interview administration (clinician versus trained 
graduate). In multiple meta-regression analysis, study design remained a significant predictor of 
heterogeneity. Global rates of Cluster-A, B and C personality disorders were 3.8 % (3.2, 4.4%), 
2.8% (1.6, 3.7%) and 5.0% (4.2, 5.9%).  
Conclusions  
Personality disorders are prevalent globally. Nevertheless, pooled prevalence rates should be 
interpreted with caution due to high levels of heterogeneity. More large-scale studies with 
standardised methodologies are now needed to increase our understanding of population needs 
and regional variations.     
Key words: Personality disorder, prevalence, systematic review, meta-analysis, LAMIC  
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Introduction  
Before the 1960s, personality disorders were viewed as unreliable diagnoses of limited clinical 
utility. Personality disorders are now recognised as important conditions, which are associated 
with morbidity, premature mortality, and great personal and social costs. 1-3  
A recent narrative review reported relatively high rates of personality disorders (4.4% - 
21.5%) in community populations across the Western world.4 To the best of our knowledge, 
however, there are no reviews examining global prevalence of personality disorders, and whether 
rates vary between high and low-and middle-income (LAMI) countries. This is important 
because personality disorders are often under-recognised in clinical practice, especially in 
LAMICs where there are limited resources and other disorders such as and psychosis tend to be 
prioritised.5 Approximately 80% of the global population live in LAMICs, and mental health is 
now recognised as a public health priority in these areas.6 Nevertheless, personality disorders are 
not included within the scope of policy-informing initiatives, such as the WHO Mental Health 
Gap Action Programme7 and the Global Burden of Diseases Project. 8 Consequently, there are 
no data to guide health policy and planning for personality disorders in LAMICs. 9,10 Personality 
disorders are associated with high levels of mental, physical, and functional impairment and 
premature mortality. 1,11 Neglecting their effects at the population level is likely to impede 
progress in reducing the burden of disability.8 Therefore, the main aim of this study was to 
conduct a systematic review of the literature on the prevalence of personality disorders to answer 
the following research questions:  
 What is the global pooled prevalence of any personality disorder in the community? 
 What is the prevalence of Cluster A, B, and C personality disorders in the community? 
 Do pooled personality disorder prevalence rates differ between high and LAMI 
countries?  
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 Do methodological factors (population characteristics, sample characteristics, study and 
assessment methods) explain variability in prevalence estimates across studies? 
 
Method 
We conducted the review in accordance with PRISMA12 and MOOSE guidelines.13 The protocol 
was registered with PROSPERO prior to conducting searches (registration number: 
CRD42017065094).  The completed review remains aligned with the original PROSPERO 
protocol in terms of search strategy, research questions and methodology; however, we could 
not examine the effects of some of the pre-selected potential moderators of prevalence figures 
(e.g., sex and ethnicity of sample) as there was insufficient data.   
 
Eligibility criteria  
We included studies:  
1) That were cross-sectional or longitudinal (i.e., personality disorder were assessed during 
one wave of the study) 14 and reported a prevalence figure for any personality disorder or 
a Cluster A, B or C personality disorder. We did not limit to a specific diagnostic criteria 
(e.g., DSM-IV or ICD-10).14   
2) Sampling adolescents (age 12-18 years) or adults from community or school populations. 
In line with recent Cochrane reviews,15 we elected to include adolescent populations, 
supported by strong evidence for the validity of personality disorders in individuals under 
18 years. 11,16,17 
3) Using validated interviews or self-report questionnaires. We included self-report 
questionnaires in the first instance to examine the impact (e.g., potential inflation) of this 
type of assessment on prevalence estimates.18  
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4) Published in any language with an English abstract (we found that all foreign language 
studies identified provided an English abstract). 
5) Published in a peer-reviewed journal. 
We excluded studies:  
1) With participants from clinical, medical, psychiatric, or prison settings.  
2) With selective samples (e.g., chronic pain groups, students in higher education, case-control 
samples). 
3) With less than 100 participants.19  
4) That adopted a retrospective diagnostic approach based on previously recorded data from 
primary or secondary care records or national registries.20 Results from clinical records or 
administrative databases might diverge from epidemiological surveys, as personality disorders are 
often underdiagnosed in these sources, 21 while register-based diagnoses might lack the reliability 
achieved by well-trained interviewers. 22   
 
Search strategy, study selection and critical appraisal 
We searched PsycINFO, MEDLINE, EMBASE, and PubMed from January 1980 to May 2017 
for articles without language restrictions. We updated the search on the 24th May 2018. We 
combined the following three search strings: Personality disorder* OR Axis-II AND Prevalen* 
OR rate* OR frequency OR percentage AND epidemiolog* OR communit* OR general 
population OR population OR student* OR healthy sample OR normal population OR 
representative sample* (see online Table DS1 for more details on search strategy). Search results 
from each database were downloaded into EndNote X7 and merged into one file. We removed 
duplicates during the merging process and imported the endnote file into the Covidence web-
based review management tool (https://www.covidence.org/about-us). We inspected the 
reference lists of retrieved articles and cross-referenced our findings against published reviews.   
2-4,23,24 Following removal of duplicates, C.W. and A.B. independently screened titles and abstracts 
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of all potentially eligible articles for full text retrieval. C.W and A.B then independently screened 
full text articles for inclusion in the review. Screening at both stages was conducted within the 
Covidence review management tool, which allowed each researcher to vote ‘yes’ or ‘no’ for each 
article and record the reason for their decision.  
 
Data extraction and critical appraisal  
C.W. extracted data using a pre-determined form. Details included: first author and year, country, 
income status of country (LAMI versus high), sample (number, age and gender), sample frame 
(including origin, recruitment and estimation), diagnostic assessment method, evaluation 
instrument, diagnostic criteria, and personality disorder prevalence figure (and standard error). 
C.W. critically appraised full text articles using an adapted version of the Joanna Briggs 
Institute Critical Appraisal Tool for prevalence reviews.25 Each study was rated (0 = study did 
not satisfy category or it could not be determined; 1=study satisfied the category). We examined 
eight categories: 1) representativeness of target population; 2) recruitment of participants; 3) 
sample size; 4) description of study subjects and setting; 5) coverage of identified sample; 6) 
objectivity of assessment; 7) reliability of the assessment; and 8) appropriate statistical analysis. 
We calculated a critical appraisal score for each study ranging from 0 to 8, which was included as 
a moderator in the meta-regression analysis.  
 
Summary measure  
Prevalence figure was the principal summary measure. ‘Any personality disorder’ referred to the 
presence of one or more categorical personality disorder as defined and assessed in each of the 
included studies. Cluster A, B and C personality disorders correspond to the three-cluster model 
of personality disorders delineated in the DSM-5. Cluster A (also known as odd-eccentric) 
included any categorical paranoid, schizotypal, or schizoid personality disorder. Cluster B (also 
known as dramatic-erratic) included any categorical histrionic, borderline, narcissistic or 
 
 
 8 
 
antisocial personality disorder. Cluster C (also known as anxious-fearful) included any categorical 
avoidant, dependent or obsessive compulsive personality disorder.26 We also pooled the 
prevalence rates of individual personality disorders (e.g., borderline personality disorder) where 
the data was available (see data supplement).  
 
Synthesis of results  
We combined prevalence figures from individual studies quantitatively using meta-analysis. In 
meta-analysis, the pooled prevalence estimate is calculated by assigning a ‘weight’ to each study, 
which reflects the accuracy of each individual study estimate and is typically a function of sample 
size.27 We used the metaprop command in STATA version 14. The metaprop command is an 
extension of the metan procedure designed for meta-analysis of proportions. As we anticipated 
heterogeneity across studies, we chose the random effects model with inverse variance weights.28 
We used the cimethod (exact) command and the Freeman-tukey double arcsine transformation 
(ftt) for meta-analyses when studies had zero prevalence rates (i.e., studies of individual 
personality disorders).29 We report heterogeneity with the I2 statistic (descriptive statistic 
representing proportion of total variability in prevalence estimates that can be attributed to 
heterogeneity), the Q statistic with p-value (measure of weighted squared deviations around the 
summary estimate), and Tau2 (inter-study variance reported in the scale of the prevalence 
estimate).30  We conducted the meta-analysis in the following stages: 1) we pooled prevalence 
figures for any personality disorder; 2) we pooled prevalence figures for Clusters A, B and C-
personality disorders respectively; 3) we pooled prevalence figures for individual personality 
disorders.  
 
Additional analyses  
Sensitivity analysis and publication bias 
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We conducted sensitivity analysis to evaluate the influence of each study on pooled personality 
disorder prevalence using the metaninf command. 31 We also examined the impact of self-report 
questionnaires on prevalence figures, as they have been associated with the over-diagnosis of 
personality disorders. 32,33 We compared pooled rates of self-report questionnaire versus 
interview studies. In line with recent prevalence studies, we assessed publication bias by visually 
inspecting the funnel plot for asymmetry.34,35 
 
Subgroup analysis and meta-regression analysis  
We used sub-analysis and meta-regressions to examine the effects of study characteristics on 
personality disorder prevalence estimates. We selected study factors a priori based on previous 
reviews of mental health prevalence 14,36 and the assessment of personality disorder prevalence 
specifically. 37-39 We conducted univariate meta-regressions for each factor. Covariates associated 
with heterogeneity at the p<0.05 level were included in the multivariate analysis.  
 
We considered the following factors for any personality disorder prevalence:  
1) Population characteristics  
 Income level of study country (1= high income; 2= LAMI - including upper-middle, 
lower-middle and low income). We used the World Bank definitions of country income 
status, which are based on Gross National Income per capita calculated using the Atlas 
method (www.worldbank.org). 
 Study date (1= before median of 2009; 2= median date or later).40  
2) Sample characteristics  
 Sample size (1= below median: n < 1, 610; 2= median or greater n= ≥ 1, 610).41  
3) Study characteristics 
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 Representativeness and sampling strategy (1=country or large city/area weighted to 
represent population; 2=medium or small city/area with complex sampling to improve 
representativeness; 3= probably non-representative sample including a small area/sample 
with no complex sampling approach).14  
 Study design (1=one-stage; 2= two-stage assessment). One-stage assessment included 
studies that administered one personality disorder assessment to the whole sample. Two-
stage assessment included studies that administered a screening instrument to the entire 
sample, and then a diagnostic interview to a proportion of individuals screening positive 
and/or negative. 14  
 Critical appraisal score (on a scale from 0 to 8) based on the Joanna Briggs Institute 
Critical Appraisal Tool for prevalence reviews. 
4) Assessment methods  
 Diagnostic criteria according to the two most used most systems in psychiatry: the 
International Classification of Diseases and the Diagnostic Statistical Manual of Mental 
Disorders (1=ICD 8/9/10; 2=DSM-III/R; 3=DSM-IV)14  
 Interview administration (1= interview by experienced clinician or psychiatrist 2= 
interview by trained graduates or research assistants; 3 = interview by trained lay 
person).41 
 Diagnostic interview (1=clinical interview; 2=Structured Clinical Interview for DSM-IV: 
SCID-II; 3=International Personality Disorder Examination: IPDE; 4=Structured 
Interview for DSM-IV Personality/Revised: SIDP-IV; 5=other, e.g., assessment tool 
used in just one study, e.g., Standard Assessment of Personality).14 
To avoid duplication, we did not repeat all the above subgroup analysis for Clusters A, B and C 
PD. We did, however, examine whether each of the clusters varied in prevalence according to 
country income level. 42 
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Results  
Study selection 
Of the original 3876 abstracts, 535 articles were selected for full text review. There was an 
acceptable level of agreement between raters (Kappa = 0.80). The updated search yielded a 
further 458 abstracts, of which 20 full text articles were retrieved for inspection. Three articles 
were identified by hand search. In total there were 558 full text articles. Of the full text articles, 
46 fulfilled our inclusion criteria (reporting on any, a Cluster A, B or C or an individual 
personality disorder). Inter-rater reliability was acceptable (Kappa = 0.82). The authors discussed 
discrepancies at the abstract and full text stage. Most discrepancies related to uncertainty relating 
to duplicate data or whether the study sample was selective (Figure 1).  
 
[Insert Figure 1 here] 
 
See online Table DS2 for a full list of excluded studies and reasons for exclusion. Main reasons 
for exclusion included: duplicate samples (e.g., National Epidemiologic Survey of Alcohol and 
Related Conditions), the use of selected samples (e.g., small undergraduate populations, case 
control studies) and very small sample size (<100 participants). Reasons for exclusion sometimes 
overlapped, e.g., studies with a small number of participants tended to use biased samples. 
 
Study characteristics  
Forty-six studies from twenty-one different countries satisfied our inclusion criteria. Thirty-four 
studies reported a prevalence figure for ‘any personality disorder’ and/or cluster A, B or C 
personality disorder (some of these studies also reported a prevalence figure for an individual 
personality disorder). Twelve studies only reported a prevalence figure for an individual 
personality disorder, e.g., Obsessive Compulsive Personality Disorder.43 See online Table DS3 
for an overview of included studies, including sample description, sampling frame, diagnostic 
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approach, and raw prevalence figures. One study from the WHO World Mental Health Surveys 
42 provided independent prevalence estimates for eight different countries. Most studies were 
published in English language, excepting two German,44,45 one Icelandic 46 and four Chinese 47-50 
articles. A.W. translated and extracted data from the Chinese publications. We could not identify 
native speakers for the German and Icelandic articles. Thus, in line with previous studies 51,52 we 
used Google Translate for these articles.   
 
Critical appraisal of included studies 
Please refer to online table DS4 for an overview of the risk of bias analysis. Lower scores 
indicate a higher chance of bias in prevalence estimates (e.g., due to lack of sample 
representativeness or measurement reliability).25 Studies ranged in scores between 2 and 7.5, with 
a mean score of 5.1. Generally, self-report questionnaire studies 46,53 and those with less robust 
recruitment strategies (e.g., non-randomisation) 54 yielded the lowest scores.  
 
Sensitivity analysis  
We included thirty studies (37 individual prevalence estimates) in the initial meta-analysis of the 
pooled prevalence of any personality disorder. Inspection of the forest plot highlighted one 
Jamaican study 55 as an outlier, with a personality disorder prevalence of 41.4%. Assessment in 
this study was conducted with the Jamaica Personality Disorder Inventory (JPDI), which 
identifies a cut-point of ≥10 as indicative of the presence of a personality disorder.56 In a 
previous study of 200 Jamaican patients, the JPDI demonstrated a reasonable level of internal 
consistency, sensitivity, specificity and concurrent validity. 56 However, the authors described the 
JPDI diagnosis as existing on a continuum from mild to severe, which might explain the very 
high rates reported. Sensitivity analysis (online Table DS5) confirmed that removal of this study 
had a relatively substantive effect on overall pooled prevalence, thus we excluded it from further 
analysis.  
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Six of the included studies used validated self-report questionnaires. 32,46-48,53,57 Self-report 
questionnaire studies (11.2%; 95% CI: 3.7, 18.7%) yielded noticeably higher pooled personality 
disorder prevalence rates than the interview studies (7.7%; 95% CI: 6.0, 9.4%). We thus excluded 
these studies from the final analysis. Twenty-four studies (providing thirty-one independent 
prevalence estimates) were included in the final meta-analysis of any personality disorder. Twelve 
studies (nineteen estimates) reported on Cluster-A, Cluster-B, and Cluster-C personality 
disorders.   
 
Pooled prevalence of any personality disorder 
The global pooled prevalence of any personality disorder was 7.8% (95% CIs: 6.1, 9.5). There 
was substantial inter-survey heterogeneity amongst estimates (I2 = 99.7%, Q = 8511.9, df=29, 
p<.001, Tau2 = 0.002). See Figure 2 for the forest plot of prevalence estimates from individual 
studies.  
[Insert Figure 2 here] 
 
Publication bias 
The funnel plot (online figure DS1) indicated a possibility of a publication bias towards higher 
personality disorder rates as reflected by the higher number of study points on the right-hand 
side of the plot.  
 
Subgroup analysis and univariate meta-regressions according to study characteristics  
See Table 1 for results of the sub-analyses and univariate (unadjusted) meta-regressions. Pooled 
prevalence rates of any personality disorder were significantly greater in high income compared 
to LAMI countries (Figure 3), with income status of country accounting for 18.7% of between 
study variance. Studies using two-stage assessments (e.g., screening tool then interview) yielded 
significantly lower pooled prevalence rates than one-stage assessments, accounting for 34.8% of 
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between study variance. Studies with interviews conducted by trained graduates or psychologists 
yielded significantly higher prevalence rates than those conducted by experienced clinicians 
(accounting for 19.5% of between study variance). 
 
[Insert Figure 3 here] 
 
[Insert Table 1 here] 
Multiple meta-regression 
In the multiple meta-regression analysis (adjusting for all significant moderators from the 
univariate meta-regression), study design (β = -.053, p = .013) remained a significant predictor of 
heterogeneity. The distinction between high and LAMI countries (β = .0002, p=0.994) and type 
of interviewer - experienced clinicians versus trained graduates (β = .041, p = .053) did not 
remain significant predictors of heterogeneity. The final model accounted for just under 40% of 
the heterogeneity in prevalence rates across studies (Adjusted R-squared: 39.6%).  
 
Prevalence of Cluster A, B and C PDs 
See Figure 3 for an overview of Cluster A, B and C personality disorder prevalence rates by 
country income classification. Twelve studies (19 estimates) examined Cluster-A prevalence 
(pooled prevalence: 3.8 %; 95% CIs: 3.2-4.4; I2 =94.3%, Q=317.6, df=18, p<.001, Tau2=0.0002). 
Two studies (8 estimates) reported prevalence rates in LAMI countries (3.4%; 95% CI =2.3-
4.5%; I2 =94.8%, Q=134.8, df=7, p<.001) and eleven (12 estimates) in high income countries 
(pooled prevalence 4.2%; 95% CI: 3.3-5.0%; I2 =94.2%, Q=173.4, df = 10, p<.001). Country 
income status was not significantly associated with Cluster-A prevalence estimates in the meta-
regression analysis (β = .002, p=0.84).  
Twelve studies (19 estimates) reported Cluster-B prevalence (2.8%; 95% CIs: 1.8-3.7; I2 
=98.8%, Q=1498.6, df=18, p<.001, Tau2=0.0004). Three studies (8 estimates) reported 
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prevalence rates in LAMI countries (1.5%; 95% CI =0.9-2.1%; I2 =93.2%, Q=103.3, df=7, 
p<.001) and ten (11 estimates) in high income countries (pooled prevalence 3.7%; 95% CI: 2.3-
5.2%; I2 =98.9%, Q=912.1, df=10. p<.001). Country income status was significantly associated 
with Cluster-B prevalence estimates in the meta-regression analysis (β = -.019, p=0.048).  
Twelve studies (19 estimates) reported Cluster-C prevalence (5.0%; 95% CIs: 4.2-5.9; I2 
=98.1%, Q=737.6, df= 18, Tau2 =0.0003). Three studies (8 estimates) reported prevalence rates 
in LAMI countries (3.3%; 95% CI =2.2-4.4%; I2 =95.7%, Q=163.2, df=7, p<.001) and eleven 
(12 estimates) in high income countries (pooled prevalence 6.6%; 95% CI: 5.1-8.1%; I2 =98.2%, 
Q=558.1, df=10, p<.001). Country income status was not significantly associated with Cluster-C 
prevalence estimates in the meta-regression analysis (β = -.028, p=0.165). 
 Pooled rates of individual personality disorders are reported in online Table DS6. The 
most common personality disorders were obsessive compulsive (3.2%), avoidant (2.7%) and 
paranoid (2.3%). Schizotypal (0.8%), histrionic (0.6%), and dependent (0.8%) personality 
disorders were rare. We did not examine pooled prevalence rates according to country income as 
most studies were from high income countries.  
 
Discussion  
We identified forty-six studies from twenty-one different countries spanning six continents 
(Africa, North America, South America, Asia, Australia/Oceania and Europe). Twenty-three 
studies (30 estimates) were included in the final meta-analysis for any PD, and twelve for the 
meta-analyses of Cluster A and B-personality disorders, and thirteen for Cluster C personality 
disorders. The global pooled prevalence of any personality disorder was 7.8% (95% CI: 6.1-9.5). 
This figure exceeds the WHO World Mental Health personality disorder prevalence estimate of 
6.1%,42 and global period prevalence rates of mood (5.4%) and anxiety (6.7%) disorders.36 We 
found significant heterogeneity across studies, which was partly explained by study design (i.e., 
two-stage assessment led to significantly lower pooled prevalence). The pooled prevalence of any 
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personality disorder was significantly lower in LAMI (4.3%) than in high income (9.4%) 
countries in univariate meta-regression, although this difference became non-significant in the 
final meta-regression. Cluster B (1.5% vs 3.7%, p=0.048) and C personality disorders (3.3% vs 
6.6%, ns) were also less common in LAMI countries.  
There are several plausible explanations for these findings. First, there might exist a lower 
population risk in LAMICs due to key cultural or social factors.2,36,58,59 Previous global reviews 
indicate lower rates of depression and anxiety in LAMICs, 36,60 and it is plausible that variations 
in behavioural norms across countries (e.g., individualistic versus collectivist societies) could have 
some bearing on personality disorder prevalence. For example, studies in urban and rural areas 
of Taiwan indicate very low prevalence rates of antisocial personality disorder. 61 It is 
hypothesised that these lower rates might be attributable to stronger social control mechanisms 
preventing the progression of antisocial behaviours. 62 Similarly, some diagnostic traits and 
categories might not be equally valid or meaningful in all countries. Avoidant, dependent and 
borderline personality disorder, for example, are not specified in the Chinese Classification of 
Mental Disorders.58 We still know relatively little about the impact of culture, race and ethnicity 
on mental disorders in general, and personality disorders specifically.58,63 It might be that certain 
illnesses, such as eating disorders (and possibly some forms of personality disorder), become 
more widespread with the increasing “Westernisation” of the world.64 Paris and Lis have 
hypothesised that borderline personality disorder (BPD) is “socially sensitive” and that secular 
trends, such as the breakdown of social cohesion and social capital, which are increasingly 
evident with rising income and inequality, have given rise to increased prevalence of BPD. 65 
Second, it is recognised that mental disorders can present with different symptoms in 
different cultures 66 and current diagnostic tools and criteria might underestimate the prevalence 
of personality disorders in LAMICs.67 Two Asian studies, conducted by Western psychiatrists, 
reported strikingly low personality disorder prevalence rates in China 68 and Bangladesh. 69 In 
contrast, the WHO mental health survey reported a prevalence of 4.1% in China when using the 
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cross-cultural International Personality Disorder Examination tool. 42,70 While the use of uniform 
(cross-cultural) assessment tools might improve inter-country comparisons, researchers should 
also consider cultural nuances in symptom clusters, which could moderate aetiology and illness 
presentation.71  
Third, differences in pooled prevalence might be partly attributable to methodological 
confounders. Study design was a strong predictor of heterogeneity in both univariate and 
multiple meta-regression analysis, while country income and interview administration became 
non-significant predictors of heterogeneity in the final multivariate model. Thus, study design 
might have confounded the effect of study country on prevalence estimate (i.e., all one-step 
studies were from high income countries potentially inflating the gap between high and LAMI 
countries). To further explore the effects of this potential methodological confounder on 
prevalence rates in high versus LAMI countries, we conducted post hoc subgroup analysis 
including two-stage studies only. We found that prevalence rates in high income studies (6.6%; 
95% CI: 3.4, 9.8.%) still exceeded prevalence rates in LAMI studies (4.3%; 95% CI: 2.6, 6.1%). 
The magnitude of the difference was reduced and no longer significant in the meta-regression 
analysis, though this could be attributable to reduced power as a result of restricting the number 
of studies (n=16). Further large scale multi-country studies, with standardised methodologies are 
needed to shed further light on whether true differences exist, 42 though current diagnostic tools 
may not adequately capture subtle cultural nuances.72   
Cluster-A personality disorders were relatively common in high (4.2%) and LAMI (3.4%) 
countries. The relatively high global prevalence of Cluster-A personality disorders contrasts with 
low presentation of these disorders in clinical settings. 73 These three personality disorders 
(paranoid, schizoid and schizotypal) often receive the least research attention 74 despite being 
associated with chronic physical comorbidities including cardiovascular disease and arthritis and 
high levels of functional impairment.4  
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We noted that studies from Australia tended to report high personality disorder prevalence rates, 
though estimates varied across studies. Using the Structured Clinical Interview for DSM-IV, 
Quirk et al. 75 found a prevalence of 21.7% in an age-stratified female cohort. Moran et al. 76 
found an informant-reported (using the Standardised Assessment of Personality) prevalence of 
18.6% in a nationally representative cohort of young people. In a nationwide household study, 
Jackson, Burgess 77 reported a more conservative prevalence of 6.6% when using the 
International Personality Disorder Examination (IPDE). As personality disorders are increasingly 
recognised as a mental health priority in Australia, more population level data is expected. 78,79  
 
Methodological considerations and limitations 
There are several limitations that should be noted when considering our review findings. First, 
we identified substantial inter-study heterogeneity across all models with high and significant I2 
values. We found that heterogeneity, while slightly reduced, remained high across all subgroup 
analyses. Pooled prevalence estimates were similarly heterogeneous in previous global prevalence 
reviews on ADHD 20 and common mental disorders.14,36 It has previously been noted that 
heterogeneity statistics are sensitive to factors present in psychiatric epidemiology reviews.36 Our 
meta-analyses included epidemiological studies of considerable magnitude (i.e., thousands of 
participants), likely leading to low within study variance, which can inflate heterogeneity statistics. 
80,81 Nevertheless, it should be acknowledged that heterogeneity can affect the stability and 
interpretability of pooled prevalence estimates.36 Second, only one of our a priori selected 
covariates had a significant impact on the variability of estimates in the multiple meta-regression. 
Other factors, such as diagnostic assessment, had a noticeable effect on pooled prevalence rates 
in the subgroup analysis, but were not significant predictors in the meta-regression. Despite our 
comprehensive search, we only identified a modest number of epidemiological studies. We 
limited our systematic search to published studies, which could have led to the omission of 
potential studies (thus reducing number of studies). This could have limited our power to detect 
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significant moderators, and fully disentangle the confounding effects of inter-related 
moderators.82 Relatedly, the exclusion of unpublished studies could have potentially led to less 
precise pooled estimates.83 We found a possible publication bias towards higher personality 
disorder prevalence rates, which could have led to a slight overestimation of pooled rate. It 
should be noted, however, that the interpretation of publication bias in prevalence reviews is not 
straightforward (i.e., in studies measuring prevalence there are no negative findings) and that 
specific methods for prevalence reviews are not well established.84,85 Third, there were some 
potential moderating factors we could not include in our analysis due to insufficient data, or a 
difficulty in constructing meaningful categories. Factors such as age, sex, urbanicity and 
socioeconomic status could have an impact on personality disorder prevalence rates. 42,86 Fourth, 
because of the limited number of studies, we had to construct relatively crude categories for 
some moderators. For example, ‘LAMICs’ covered a wide variety of countries (both low-middle 
and high-middle) and included megacities 87 and rural areas, 69 all of which might vary in 
prevalence rates. Fifth, the inclusion of longitudinal cohorts could have led to an 
underestimation of personality disorder prevalence as disadvantaged or mentally ill participants 
are more likely to drop out of studies. However, the few included longitudinal studies reported 
high follow-up rates of approximately 80%. 88,89 Sixth, three of the included studies were 
translated using Google Translate. Google Translate is increasing used in systematic review 
studies and had been highlighted as a useful tool for reviewers to translate European articles. 
However, it is possible that this approach could have introduced inaccuracies.90  
Finally, we only pooled categorical personality disorder prevalence figures. The 
assumption that personality disorders are categorical is highly contested. 37 Although the DSM-5 
has retained the ten discrete personality disorders, 26 personality and personality pathology is 
dimensional.4 Under direction from the WHO, the ICD-11 Working Group is developing a 
dimensional system for the diagnosis of personality disorders, which should be usable and useful 
for health care workers in lower-resource settings, and will consider the cross-cultural 
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applicability of categories, definitions and diagnostic descriptions. 91 92 These developments could 
help in tackling the challenge of clinical utility to guide clinical decision-making and to inform 
health policy and planning across LAMIC and high-income countries.93  
 
Conclusions 
Despite substantial inter-survey heterogeneity, we found that personality disorders are prevalent 
globally affecting a substantial proportion of the population. Epidemiological research on 
personality disorders is relatively sparse, with a paucity of data from less developed countries, 
from which to draw comparative conclusions. While personality disorder prevalence rates are 
lower in LAMICs, they are still considerable.87 As personality disorders are common across many 
areas of the world, they should be recognised as an important contributor to population mental 
health and disease burden. 2,4 Personality pathology continues to be overlooked in clinical 
practice 94 particularly in LAMICs where resources are limited 95 and personality disorders tend to 
be a lower priority. 42,87 Services in lower income countries need to be structured to 
accommodate these patients, and educational programs should be offered to both specialist and 
general practitioners.87 
Treatments for patients with personality disorder have advanced considerably over recent 
years with the advent of a number of specialised psychotherapies 96 and early intervention 
programs. 79,97 Nevertheless, the evidence base is underdeveloped with the majority of studies 
pertaining to borderline personality disorder (and to a lesser extent) antisocial personality 
disorder. 74 Global prevalence rates for Cluster-A and C-personality disorders exceed those of 
Cluster-B personality disorders supporting the need for more treatment trials in these lesser 
studied disorders.74 
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Table 1. Subgroup analysis and univariate metaregression results for the diagnosis of any PD  
Methodological factor Subgroup analysis  Meta-regression analysis  
Subgroup categories (number)a Pooled 
prevalence % 
(95% CIs) 
I2 % % 
 
Q statistic 
(df) 
P-value of 
heterogeneity 
Coefficient  
(SE) 
P value 
 
Proportion of 
between-study 
variance explained 
Tau-squared 
(REML 
estimation)  
Country classification (income level)       Adjusted R2  
   High income (n=20) 9.6 (7.9, 11.3) 98.4 1212.6 (19) <0.001 (reference)    
   LAMIC (n=10)  4.3 (2.6, 6.1) 99.3 1264.2 (9) <0.001 -0.048 (0.018) 0.011 18.7% 0.002015 
Study date          
   Before median of 2009 (n=13)  8.6 (6.3, 11.0) 99.3 1771.9 (12) <0.001 (reference)    
   Equals median or later (n=17) 7.1 (5.5, 8.8) 98.8 1321.6 (16) <0.001 -0.012 (0.02) 0.542 -2.49% 0.00254 
Sample size          
   Below median: n < 1, 610 (n=16) 9.6 (7.0, 12.3) 98.0 753.5 (15) <0.001 (reference)    
   Median or greater n= ≥ 1, 610 (n=14) 5.9 (3.4, 8.4) 99.8 7227.1 (13)  <0.001 -0.030 (0.018) 0.109 5.46% 0.002343 
Sampling strategy           
   Representative (n=17) 7.5 (4.8, 10.1) 99.8 7477.6 (16) <0.001 (reference)    
   Probably representative (n=6) 7.8 (4.9, 10.8) 98.4 305.7 (5) <0.001 0.003 (0.025) 0.911   
   Unlikely representative (n=7) 8.7 (5.0, 12.5)  97.8 270.0 (6) <0.001 0.017 (0.024) 0.478 -6.04% 0.002628 
Study design          
   One-stage (n=14) 10.6 (9.0, 12.2) 96.7 390.91 (13) <0.001 (reference)    
   Two-stage (n=16) 5.1 (3.6, 6.7)  99.3 2076.7 (15) <0.001 -0.060 (0.015)  0.001 34.8% 0.001617 
Diagnostic criteria          
   ICD 8, 9, 10 (n=5) 5.6 (2.7, 8.5) 99.6 1021.8 (4) <0.001 (reference)    
   DSM-III/R (n=5) 9.4 (2.4, 16.3) 98.9 349.7 (4) <0.001 0.035 (0.033) 0.296   
   DSM-IV (n=20)  7.9 (6.2, 9.6)  98.7 1421.7 (19) <0.001 0.016 (0.026) 0.555 -2.73% 0.002546 
Diagnostic assessment         
   Experienced clinician (n=8) 4.5 (3.1, 6.0)  98.3 417.8 (7) <0.001 (reference)    
   Trained graduate (n=11) 11.3 (8.5, 14.0)  96.2 266.5 (10) <0.001 0.054 (0.022) 0.018   
   Lay interviewer (n=11) 6.0 (4.5, 7.5)  98.2 564.4 (10)  <0.001 0.008 (0.021)  0.712 19.5% 0.001995 
Study instruments           
   Clinical interview (n=2) 1.0 (0.4, 1.4) N/A N/A N/A (reference)    
   SCID-II (n=7) 12.1 (8.7, 15.5) 92.2 76.4 (6) <0.001 0.059 (0.040) 0.150   
   IPDE (n=12)  5.7 (4.3, 7.1) 97.8 500.6 (11) <0.001 0.010 (0.038) 0.790   
   SIDP (n=3) 8.8 (4.2, 13.4) N/A N/A N/A 0.043 (0.045)  0.358   
   Other (n=6) b 8.0 (3.2, 12.8) 99.9 4617.9 (5) <0.001 0.033 (0.041) 0.428 3.37% 0.002395 
Critical appraisal score (continuous)c - - - - 0.009 (0.009) 0.336 0.23% 0.002472 
REML: Restricted Maximum Likelihood method; LAMIC: Low- and middle-income countries; SCID-II: Structured Clinical Interview for DSM-IV; IPDE: International Personality Disorder Examination; SIDP: Structured Interview for 
DSM-IV Personality   
 
 
 31 
 
 
